Evidence map›Paper›PMID 30636633›Full record

ArticleDiagnostic pathology2019

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.

Yuichiro Hatano, Maho Tamada, Nami Asano, Yoh Hayasaki, Hiroyuki Tomita, Ken-Ichirou Morishige, Akira Hara

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular Trajectory ofFrontiers in oncology · 2020
    Review
  4. Article
  5. A Comprehensive Review of Ovarian Serous Carcinoma.Advances in anatomic pathology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuichiro HatanoDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan. yuha@gifu-u.ac.jp.ORCID http://orcid.org/0000-0002-5121-6325
Maho TamadaDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Nami AsanoDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Yoh HayasakiDepartment of Obstetrics and Gynecology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Hiroyuki TomitaDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Ken-Ichirou MorishigeDepartment of Obstetrics and Gynecology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Akira HaraDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Gifu University · JP

Funding

Japan Society for the Promotion of Science JP18K15207
6 · The paper itself

Abstract

backgroundHigh-grade serous carcinoma, a representative high-grade ovarian carcinoma, is believed to be closely associated with a TP53 mutation. Recently, this category of ovarian carcinoma has gained increasing attention owing to the recognition of morphological varieties of TP53-mutated high-grade ovarian carcinoma. Herein, we report the case of a patient with high-grade serous carcinoma with mucinous differentiation. CASE PRESENTATION: A 59-year-old postmenopausal woman was referred to the gynecologist because of abnormal vaginal bleeding. The radiological assessment revealed an intrapelvic multicystic mass, which was interpreted as an early right ovarian cancer and then removed by radical surgery. Histologically, the cancer cells were found in the bilateral ovaries and para-aortic lymph nodes. The cancer cells showed high-grade nuclear atypia and various morphologies, including the solid, pseudo-endometrioid, transitional cell-like (SET) pattern, and mucin-producing patterns. Benign and/or borderline mucin-producing epithelium, serous tubal intraepithelial carcinoma, and endometriosis-related lesions were not observed. In immunohistochemistry analyses, the cancer cells were diffuse positive for p53; block positive for p16; partial positive for WT1, ER, PgR, CDX2 and PAX8; and negative for p40, p63, GATA3, Napsin A, and vimentin. The Ki-67 labeling index of the cancer cells was 60-80%. Direct sequencing revealed that the cancer cells contained a missense mutation (c.730G>A) in the TP53 gene.

conclusionMucinous differentiation in high-grade serous carcinoma is a rare and unique ovarian tumor phenotype and it mimics the phenotypes of mucinous or seromucinous carcinoma. To avoid the misdiagnosis, extensive histological and immunohistochemical analyses should be performed when pathologists encounter high-grade mucin-producing ovarian carcinoma. The present case shows that the unusual histological characteristic of high-grade serous carcinoma, the "SET" feature, could be extended to the solid, transitional, endometrioid and mucinous-like (STEM) feature.

Indexed as

Biomarkers, TumorCell DifferentiationCystadenocarcinoma, SerousDiagnostic ErrorsFemaleHumansImmunohistochemistryMiddle AgedMutationNeoplasms, Cystic, Mucinous, and SerousOvarian NeoplasmsTumor Suppressor Protein p53Biomarkers, TumorTP53 protein, humanTumor Suppressor Protein p53High-grade serous carcinomaMucinous differentiationOvarySET featureTP53

Identifiers

PMID30636633
PMCPMC6330567
OpenAlexW2942673563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.